“If you’re facing a cancer diagnosis, the first shock is the disease. The second is the invoice and where you get treated can change that invoice by 90%.”

Meta Description: Compare chemotherapy costs in the US vs India what’s included, hidden fees, and payment plans. See real per-cycle pricing and save up to 90% on cancer care.

A single month of chemotherapy in the United States can run as high as $15,000 — and that’s before scans, supportive drugs, or a surprise bill from an out-of-network anesthesiologist. In India, a comparable month of treatment at a top-tier private cancer hospital often lands closer to $1,500. Same drugs. Same treatment protocols. A tenth of the price.

If you or someone you love is facing a cancer diagnosis, the financial side of that fight shouldn’t be a mystery. This guide breaks down exactly what drives chemo costs in both countries, what’s actually included in each price tag, and how payment plans work on both sides — so you can make an informed decision instead of a panicked one.

Why Chemotherapy Costs Vary So Wildly in the First Place

Chemotherapy isn’t a single, fixed-price product. The final bill depends on the cancer type and stage, the specific drug protocol (a generic IV regimen and a targeted biologic are worlds apart in cost), how many cycles are needed, and where you receive care. A hospital-based infusion suite in a major metro area will almost always cost more than the same treatment at an independent clinic, and brand-name hospitals price in their reputation along with the medicine.

That variability exists in both countries — but the baseline is what’s different. US healthcare pricing reflects higher drug list prices, higher facility overhead, and a fee-for-service billing structure where nearly every touchpoint (the infusion chair, the nursing time, the anti-nausea injection) is billed separately. Indian hospitals operate with lower staffing and infrastructure costs, government-negotiated drug pricing on many essential medicines, and — at accredited private hospitals — international patient programs built specifically around bundled, transparent pricing.

US Chemotherapy Costs: The Real Numbers

In the United States, a month of chemotherapy without insurance typically falls between $5,000 and $25,000, depending on whether the regimen is IV or oral, and which drugs are involved. Oral targeted therapies and newer biologics frequently push past $15,000 a month on their own, before administration fees are added. A full multi-cycle course (typically 4 to 8 cycles over 3 to 6 months) commonly totals $50,000 to $200,000 or more for uninsured patients.

What drives the US price tag:

• Drug cost — the single biggest line item, especially for targeted therapies and immunotherapies, which can run $10,000–$20,000 per infusion alone
• Facility/administration fee — a median infusion administration fee sits around $500 per session, separate from the drug itself
• Imaging and labs — CT and PET scans often exceed $2,000 each in the US
• Supportive medications — anti-nausea drugs, growth factor injections, and pain management, billed separately
• Out-of-network surprises — consulting oncologists, pathologists, or anesthesiologists at an in-network hospital who happen to be out-of-network themselves

Even with insurance, the picture isn’t simple. Medicare Part B covers 80% of outpatient infusion chemo — but the remaining 20% coinsurance has no annual cap under Original Medicare, meaning a $10,000-a-month regimen can still leave you owing thousands out of pocket every year. ACA marketplace plans cap annual out-of-pocket spending, but most cancer patients hit that cap simply by starting treatment, and premiums for the plans robust enough to do so aren’t cheap either.

India Chemotherapy Costs: The Real Numbers

At accredited private hospitals in India — the kind that treat international patients and hold JCI or NABH accreditation — a single chemotherapy cycle typically costs ₹20,000 to ₹1,00,000 (roughly $240 to $1,200), depending on the drug protocol. Government hospitals can be even lower, sometimes as little as ₹8,000–₹10,000 per cycle for basic regimens, though these aren’t typically set up for international patients.

Averaged across a monthly treatment cycle, most international patients land around $1,000 to $1,500 per month for standard IV or oral chemotherapy — inclusive of hospital charges, drug administration, and routine monitoring. That’s the figure that makes India one of the most cost-effective cancer care destinations in the world, without a downgrade in drug quality: the same generic and branded chemotherapy agents used in US hospitals are manufactured and administered in India, often by the same multinational pharmaceutical companies.

What’s typically included at that price:

• Oncologist consultations and treatment planning
• The chemotherapy drugs themselves (IV or oral)
• Infusion suite/day-care charges and nursing time
• Basic monitoring: blood counts before each cycle, organ function tests

What’s usually billed separately, in both countries:

• Pre-treatment diagnostics (PET-CT, biopsy, baseline bloodwork) — though even here, a PET scan in India runs roughly $70–$290 versus $2,000+ in the US
• Supportive medications (anti-nausea drugs, immunity boosters) — around ₹5,000–₹20,000 ($60–$240) per cycle in India
• A vascular access port, if needed, as a one-time cost
• Travel, accommodation, and — for international patients — visa and travel-companion costs

Figures are broad industry estimates for 2026 and vary by hospital, cancer type, and drug protocol. Always request a written, itemized estimate before treatment begins — in either country.

What “Included” Really Means: Reading the Fine Print

The single biggest source of sticker shock — in the US and in India — is assuming the headline number is the whole bill. It rarely is.

In the US, a quoted “chemo cost” is almost always just the drug and administration fee. Scans, labs, supportive drugs, and any inpatient stay are added on top, and even in-network hospitals can route part of your care through out-of-network specialists.

In India, reputable hospitals working with international patients are increasingly moving toward bundled quotes that combine the oncologist’s fee, the drug, infusion suite time, and routine monitoring into one number — but pre-treatment diagnostics, a vascular port, and post-cycle supportive medications are still commonly billed as add-ons. The fix in both countries is the same: before cycle one starts, request an itemized estimate that spells out drug cost, cycle count, monitoring, and anything not included.

Payment Plans: How Patients Actually Afford Treatment

In the United States:

• Hospital payment plans — most health systems have financial counselors who can set up zero-interest, recurring monthly payment arrangements spread over the course of treatment
• Medicare/Medicaid — Medicare Part B covers 80% of infusion chemo; Medicaid may cover treatment at little to no cost for eligible patients, including terminally ill individuals
• Medical credit lines (e.g., CareCredit) — often carry promotional interest-free periods, though rates rise sharply if a balance remains after the promo period
• Pharmaceutical patient assistance programs — many drug manufacturers offer free or discounted doses for uninsured or underinsured patients, especially for expensive targeted therapies
• Crowdfunding and nonprofit grants — increasingly common as a supplement, not a primary funding source, for gaps left by insurance

In India:

• Hospital financial counseling — leading cancer centers have dedicated teams that build a cycle-by-cycle payment schedule, often collecting per-cycle rather than requiring a lump sum upfront
• Government health schemes — Indian citizens may access subsidized or cashless treatment through schemes like Ayushman Bharat (PM-JAY) at empaneled hospitals
• Medical tourism package pricing — many hospitals offer international patients a bundled quote covering the full treatment course, sometimes with travel and accommodation coordination included
• Pharmaceutical “buy X, get Y free” programs — for high-cost immunotherapy or targeted pills, manufacturers sometimes provide additional free doses after a set number of paid doses
• Employer or international insurance — some international health policies reimburse treatment received abroad; it’s worth confirming this before booking

Is Traveling to India for Chemo Actually Realistic?

For many international patients, yes — and the infrastructure has caught up with the demand. India’s medical tourism sector serves hundreds of thousands of foreign patients a year, with oncology among the fastest-growing categories. Most countries’ citizens can apply for an e-Medical Visa, typically approved within about a week, valid for 60 days with extensions available for longer treatment courses, and a companion visa is available for a family member to travel with you.

The practical process usually looks like this: send your existing diagnostic reports and pathology results to the hospital’s international patient department, receive a treatment plan and cost estimate from an oncologist (often within 24–48 hours), get an invitation letter to support your visa application, then travel for an initial consultation, treatment, and follow-up monitoring before returning home for the remainder of your care under a local oncologist, with periodic check-ins.

It’s not the right fit for every patient — treatment that requires many closely spaced cycles over a long period may make repeated international travel impractical, and some patients understandably prefer to stay close to home during treatment regardless of cost. But for regimens with fewer, well-spaced cycles, or for a second opinion and one intensive treatment phase, the cost gap is large enough that many patients find the trip worthwhile.

Questions to Ask Before You Commit, Anywhere

Regardless of which country you’re treated in, ask for:

1. A written, itemized cost estimate — drugs, administration, monitoring, and anything excluded
2. Confirmation of exactly which cycles and scans that estimate covers
3. Whether the quoted price is negotiable or fixed
4. What happens financially if your treatment plan changes mid-course
5. Whether supportive medications and a vascular port are included or separate

The Bottom Line

Chemotherapy pricing in the US and India reflects two very different healthcare systems — one built on itemized, fee-for-service billing with high drug list prices, the other on lower overhead and increasingly bundled international-patient pricing. Neither number tells the whole story until you see it itemized. If cost is the deciding factor in your care, get quotes in writing from more than one hospital, ask what’s excluded, and loop in a financial counselor early — the earlier the conversation happens, the more options you have.